Rome Criteria for Functional Gastrointestinal Disorders

The Rome IV criteria (2016) are the current gold standard for diagnosing functional gastrointestinal disorders, though Rome V (2026) has just been released with important refinements, particularly moving away from the term "functional" toward "disorders of gut-brain interaction" (DGBI). 1, 2, 3

Core Diagnostic Framework

The Rome criteria require symptom onset at least 6 months prior to diagnosis, with symptoms active in the past 3 months for research purposes. However, for routine clinical practice, the Rome Foundation now endorses less restrictive "clinical criteria" requiring only 8 weeks of symptoms to avoid delaying diagnosis and treatment. 2

Irritable Bowel Syndrome (IBS)

Rome IV Criteria 1:

Recurrent abdominal pain, on average, at least 1 day per week in the last 3 months associated with two or more of the following:

Related to defecation (can worsen or improve with bowel movements, not just improve as in Rome III)
Associated with a change in frequency of stool
Associated with a change in stool form

IBS Subtypes Based on Bristol Stool Form:

IBS-C (constipation): ≥25% of bowel movements are Bristol types 1 or 2, and <25% are types 6 or 7
IBS-D (diarrhea): ≥25% of bowel movements are Bristol types 6 or 7
IBS-M (mixed): Does not fall into other subgroups
IBS-U (unclassified): Insufficient abnormal stools to meet other criteria

Key Rome IV Changes:

Pain is required (discomfort was eliminated as non-specific across languages)
Pain can worsen with defecation, not just improve
Frequency reduced from "at least 3 days per month" to "at least 1 day per week"

Rome V Updates (2026) 3:

Reintroduces abdominal discomfort alongside pain
Changes symptom frequency thresholds
Emphasizes gut-brain interaction mechanisms

Functional Dyspepsia (FD)

Rome IV Criteria 2:

One or more of the following bothersome symptoms (severe enough to impact usual activities):

Epigastric pain
Epigastric burning
Postprandial fullness
Early satiation

Plus:

Symptom onset at least 6 months prior to diagnosis
Symptoms active within past 3 months
No evidence of structural disease at upper endoscopy to explain symptoms

FD Subtypes:

Epigastric Pain Syndrome (EPS) 2:

Must include one or both at least 1 day per week:

Bothersome epigastric pain
Bothersome epigastric burning

Pain may be meal-induced, meal-relieved, or occur while fasting. Does not fulfill biliary pain criteria.

Postprandial Distress Syndrome (PDS) 2:

Must include one or both at least 3 days per week:

Bothersome postprandial fullness
Bothersome early satiation (prevents finishing regular-sized meal)

Important Clinical Considerations:

Overlap between EPS and PDS is common, particularly in secondary/tertiary care
Heartburn is NOT a dyspeptic symptom but may coexist
Vomiting is atypical and should prompt consideration of other disorders (e.g., gastroparesis)
Symptoms relieved by evacuation of feces/gas should not be considered dyspepsia

Clinical Criteria for Practice 2:

Only 8 weeks of cardinal symptoms required (not 6 months), otherwise unchanged. This addresses the major limitation that Rome IV's restrictive duration requirements significantly reduced FD prevalence and delayed diagnosis.

Functional Constipation (FC)

Rome IV Criteria 4:

Must include two or more of the following for at least 3 months (with symptom onset ≥6 months prior):

Straining during >25% of defecations
Lumpy or hard stools (Bristol 1-2) in >25% of defecations
Sensation of incomplete evacuation >25% of defecations
Sensation of anorectal obstruction/blockage >25% of defecations
Manual maneuvers to facilitate >25% of defecations
<3 spontaneous bowel movements per week

Plus:

Loose stools rarely present without laxative use
Insufficient criteria for IBS

Rome V Update (2026) 3:

Renamed "chronic constipation" to reduce stigma of "functional" label
Formally recognizes rectal hypo- and hypersensitivity as diagnostic entities
Operationalizes dyssynergic defecation using objective testing (anorectal manometry, balloon expulsion test)

Functional Diarrhea

Rome IV Criteria 5, 6:

Loose or watery stools (Bristol 6-7) in >25% of stools
Occurring for ≥3 months (symptom onset ≥6 months prior)
Without predominant abdominal pain (distinguishes from IBS-D)
Not meeting criteria for IBS, microscopic colitis, or other organic causes

Critical Distinction:

Rome IV significantly increased functional diarrhea prevalence (from 1.2% to 3.3%) while decreasing IBS prevalence (from 4.0% to 0.8%), as many Rome III IBS patients were reclassified. 6

Key Clinical Pitfalls and Caveats

1. Rome IV vs Clinical Practice 2:

The 6-month symptom onset requirement is too restrictive for clinical practice. Use the 8-week clinical criteria to avoid delaying diagnosis and treatment.

2. Global Prevalence Variations 1:

Rome IV criteria are more specific but less sensitive than Rome III
Global IBS prevalence: 4.1% (Rome IV) vs 10.1% (Rome III)
FD prevalence similarly reduced with Rome IV

3. Overlap Syndromes 6:

52.5% of Rome III IBS patients who didn't meet Rome IV criteria fulfilled criteria for FC, functional diarrhea, FD, or overlap syndrome. Always assess for multiple DGBIs.

4. Organic Mimickers 7:

Before finalizing DGBI diagnosis, rule out:

Small intestinal bacterial overgrowth (SIBO)
Non-celiac gluten sensitivity
Microscopic colitis
Post-infectious etiologies (including post-COVID)

5. FD vs Gastroparesis 2:

These are symptom-based constructs with significant overlap that cannot be fully distinguished by symptoms or gastric emptying studies alone. Consider using "FD with or without delayed gastric emptying" rather than overemphasizing motor deficits.

6. Terminology Evolution 5, 3:

Rome IV introduced "disorders of gut-brain interaction" (DGBI)
Rome V (2026) deliberately moves away from "functional" to reduce stigma
However, individual disorders still retain "functional" in their names (e.g., functional dyspepsia)

Diagnostic Approach Algorithm

Identify cardinal symptoms and duration (8 weeks for clinical practice, 6 months for research)
Screen for alarm features: unintentional weight loss, progressive dysphagia, persistent vomiting, GI bleeding, family history of GI malignancy, age >50 with new symptoms
Perform appropriate investigations to exclude organic disease:
- Upper endoscopy for dyspepsia
- Colonoscopy for constipation/diarrhea if alarm features present
- Consider anorectal manometry for refractory constipation
Apply Rome criteria to classify specific DGBI
Assess for overlap syndromes (common in 40-50% of patients)
Consider organic mimickers if refractory to standard treatment

Impact on Healthcare

All FGIDs/DGBIs significantly impact quality of life and healthcare utilization regardless of Rome III vs IV criteria. 6 IBS alone costs €8 billion annually in Europe and >$10 billion in the USA, with 25% of patients reporting work absences and 80% experiencing presenteeism. 1

What are the Rome criteria for diagnosing functional gastrointestinal disorders, including irritable bowel syndrome, functional dyspepsia, functional constipation, and functional diarrhea?

Have a follow-up question?